AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nuvectis Pharma, Inc. Director's Dealing 2022

Mar 24, 2022

33912_dirs_2022-03-24_072c8b54-e22a-49f3-b5a0-b1bef59c72f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2022-03-18

Reporting Person: Carson Michael J. (Vice President, Finance)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	27300	Direct

Footnotes

F1: Represents Restricted Stock Units (RSUs) granted on November 1, 2021. These RSUs vest over a 3-year period, with 1/3 vesting on each of the first three anniversaries of the grant date.